Characterization of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream isolates at a Taiwanese hospital: Clinical impacts of lowered breakpoints for carbapenems

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 1941-1950

  Lee, N Y ^a   Wu, J J ^b   Lin, S H ^a   Ko, W C ^a   Tsai, L H ^b   Yan, J J ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CMY; BETA LACTAMASE CTX M; BETA LACTAMASE DHA; BETA LACTAMASE IMP; BETA LACTAMASE KPC; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; BETA LACTAMASE VIM; CARBAPENEM; CEFMETAZOLE; CEFOXITIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN K35; OUTER MEMBRANE PROTEIN K36; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DISK DIFFUSION; ENZYME SYNTHESIS; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84866390559     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1525-2     Document Type: Article

References (31)

1. Pitout JD (2010) Infections with extended-spectrum β- lactamaseproducing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333
2. Jean SS, Hsueh PR (2011) High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 37:291-295
3. Bush K (2010) Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol 13:558-564
4. Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y (2009) Emergence of carbapenem-nonsusceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol 58:912-922
5. Kim SY, Park YJ, Yu JK, Kim HS, Park YS, Yoon JB, Yoo JY, Lee K (2007) Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates. Diagn Microbiol Infect Dis 57:85-91 (Pubitemid 44908824)
6. Doumith M, Ellington MJ, Livermore DM, Woodford N (2009) Molecular mechanisms disrupting porin expression in ertapenemresistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659-667
7. Wang XD, Cai JC, Zhou HW, Zhang R, Chen GX (2009) Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiency. J Med Microbiol 58:1196-1202
8. Song W, Suh B, Choi JY, Jeong SH, Jeon EH, Lee YK, Hong SG, Lee K (2009) In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment. Diagn Microbiol Infect Dis 65:447-449
9. Cuzon G, Naas T, Guibert M, Nordmann P (2010) In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extendedspectrum β-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. Int J Antimicrob Agents 35:265-268
10. LeeK, Yong D, ChoiYS, YumJH, KimJM,Woodford N, Livermore DM, Chong Y (2007) Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int J Antimicrob Agents 29:201-206 (Pubitemid 46073670)
11. Clinical and Laboratory Standards Institute (CLSI) (2009) Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. CLSI document M100-S19. CLSI, Wayne, PA
12. Clinical and Laboratory Standards Institute (CLSI) (2011) Performance standards for antimicrobial susceptibility testing. Twentyfirst informational supplement. CLSI document M100-S21. CLSI, Wayne, PA
13. Pasteran F, Lucero C, Soloaga R, Rapoport M, Corso A (2011) Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae? J Clin Microbiol 49:697-701
14. Yan JJ, Hsueh PR, Lu JJ, Chang FY, Shyr JM, Wan JH, Liu YC, Chuang YC, Yang YC, Tsao SM, Wu HH, Wang LS, Lin TP, Wu HM, Chen HM, Wu JJ (2006) Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob Agents Chemother 50:1861-1864
15. Wu JJ, Wang LR, Liu YF, Chen HM, Yan JJ (2011) Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital. Microb Drug Resist 17:259-266
16. Yan JJ, Ko WC, Wu HM, Tsai SH, Chuang CL, Wu JJ (2004) Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 42:5337-5340
17. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, Lee KM (2007) Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 57:315-318 (Pubitemid 46330652)
18. Yan JJ, Wu JJ, Tsai SH, Chuang CL (2004) Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn Microbiol Infect Dis 49:5-11
19. Yigit H, Queenan AM, Anderson GJ, Doménech-Sánchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161 (Pubitemid 32230996)
20. Nüesch-Inderbinen MT, Hächler H, Kayser FH (1996) Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 15:398-402 (Pubitemid 26181640)
21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239
22. Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C (1993) Comorbidity of chronic diseases in general practice. J Clin Epidemiol 46:469-473 (Pubitemid 23194269)
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383 (Pubitemid 17055592)
24. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140
25. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140:26-32 (Pubitemid 38055918)
26. Jacoby GA (2009) AmpC β-lactamases. Clin Microbiol Rev 22:161-182
27. Wexler HM (2004) In vitro activity of ertapenem: review of recent studies. J Antimicrob Chemother 53(Suppl 2):ii11-ii21
28. Yoo JS, Byeon J, Yang J, Yoo JI, Chung GT, Lee YS (2010) High prevalence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea. Diagn Microbiol Infect Dis 67:261-265
29. Mammeri H, Guillon H, Eb F, Nordmann P (2010) Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases. Antimicrob Agents Chemother 54:4556-4560
30. Doménech-Sánchez A, Martínez-Martínez L, Hernández-Allés S, del Carmen Conejo M, Pascual A, Tomás JM, Albertí S, Benedí VJ (2003) Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother 47:3332-3335 (Pubitemid 37229599)
31. Jacoby GA, Mills DM, Chow N (2004) Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:3203- 3206 (Pubitemid 38989206)